Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  de Castro, Carlos A V ^a,b   Grinsztejn, Beatriz ^b   Veloso, Valdiléa G ^b   Bastos, Francisco I ^c   Pilotto, José H ^a,b,d   Morgado, Mariza G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c Brazil   (Brazil)

^d HOSPITAL GERAL DE FORTALEZA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOPROTEIN GP 120; POL PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; HEALTH SERVICE; HELP SEEKING BEHAVIOR; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PATIENT COUNSELING; PHYLOGENY; SEROPREVALENCE; VIRUS GENOME; CHEMISTRY; CLASSIFICATION; GENETICS; GENOTYPE; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE; URBAN POPULATION; VIROLOGY;

ADULT; BRAZIL; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMAN EXPERIMENTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; SEQUENCE ANALYSIS, DNA; URBAN POPULATION; YOUNG ADULT;

EID: 77955561662     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-224     Document Type: Article

References (44)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) AIDS epidemic update. 2009, 100. Geneva, Switzerland, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO).
2. Bastos FI, Caceres C, Galvao J, Veras MA, Castilho EA. AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int J Epidemiol 2008, 37(4):729-737.
3. PN - DST/AIDS Ministério da Saúde Boletim Epidemiológico AIDS DST. Ministério da Saúde, Janeiro a Junho de 2009 2009, PN - DST/AIDS Ministério da Saúde.
4. Bastos FI, Nunn A, Hacker MA, Malta M, Szwarcwald CL. AIDS in Brazil: The challenge and the response. Celentano DD & Beyrer C: Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care 2008, 629-654. New York: Springer International.
5. PN - DST/AIDS Ministério da Saúde Contribution of the Test and Counselling Centers to Universalize the Diagnosis and Guarantee the Equality in the Access to the Services. Ministério da Saúde 2008, PN - DST/AIDS Ministério da Saúde.
6. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Jama 1998, 280(1):42-48. 10.1001/jama.280.1.42, 9660362.
7. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res 2005, 121(4):510-518.
8. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008, 13(36):314-320.
9. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002, 18(4):295-307. 10.1089/088922202753472874, 11860677.
10. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004, 42(6):2623-2628. 10.1128/JCM.42.6.2623-2628.2004, 427871, 15184443.
11. UNAIDS Reference Group on estimates, modelling and projections Statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Wkly Epidemiol Rec 2006, 81(4):40. UNAIDS Reference Group on estimates, modelling and projections.
12. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006, 22(10):945-952. 10.1089/aid.2006.22.945, 17067263.
13. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, Chidawanyika H, Moulton LH, Ward B, Nathoo K, Iliff PJ, Kopp E. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008, 22(4):511-518. 10.1097/QAD.0b013e3282f2a960, 18301064.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor Laboratory, NY 1989, 458.
15. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rübsamen-Waigmann H, Mullins JI. Genetic Relationships Determined by a DNA Heteroduplex Mobility Assay: Analysis of HIV-1 env genes. Science 1993, 262:1257-1261. 10.1126/science.8235655, 8235655.
16. Eyer-Silva WA, Morgado MG. A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality. Mem Inst Oswaldo Cruz 2005, 100(8):869-873. 10.1590/S0074-02762005000800008, 16444418.
17. Eyer-Silva WA, Morgado MG. Molecular epidemiology of HIV-1 infection in a small Brazilian county: usefulness of envelope and polymerase sequences to epidemiologic studies. J Acquir Immune Defic Syndr 2006, 41(5):664-670. 10.1097/01.qai.0000194736.66322.02, 16652042.
18. Burland TG. DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 2000, 132:71-91.
19. Thompson JD, Higgins DG, Gibson TJ. Clustal W: Improving the sensitivity of progressive multiple sequence alignment, through sequence weighting, position-sepecific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680. 10.1093/nar/22.22.4673, 308517, 7984417.
20. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004, 5(2):150-163. 10.1093/bib/5.2.150, 15260895.
21. Page RD. Treeview: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996, 12(4):357-8.
22. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, van Rensburg EJ, Wensing AM, van de Vijver DA, Boucher CA, Camacho R, Vandamme AM. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005, 21(19):3797-3800. 10.1093/bioinformatics/bti607, 16076886.
23. Guimarães ML, Eyer-Silva WA, Couto-Fernandez JC, Morgado MG. Identification of two new CRF_BF in Rio de Janeiro State, Brazil. AIDS 2008, 22(3):433-5. 10.1097/QAD.0b013e3282f47ad0, 18195572.
24. Schechter M, do Lago RF, de Melo MF, Sheppard HW, Guimarães NC, Moreira RI, Faulhaber JC, Batista S, Harrison LH. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group. J Acquir Immune Defic Syndr 2000, 24(2):175-7.
25. Barroso PF, Harrison LH, de Fatima Melo M, Batista SM, da Silva Bastos M, da Rosa Faulhaber JC, Moreira RI, do Lago RF, Schechter M. Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: an update. J Acquir Immune Defic Syndr 2004, 36(3):880-881.
26. Alves K, Shafer KP, Caseiro M, Rutherford G, Falcao ME, Sucupira MC, Busch MP, Rawal BD, Diaz RS. Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999. J Acquir Immune Defic Syndr 2003, 32(5):551-559. 10.1097/00126334-200304150-00014, 12679709.
27. Bassichetto KC, Bergamaschi DP, Veras MA, Sucupira MC, Mesquita F, Diaz RS. Estimating HIV-1 incidence using the serologic testing algorithm for recent HIV infections at HIV counseling and testing centers in the city of São Paulo, Brazil. Braz J Infect Dis 2009, 13(1):9-12. 10.1590/S1413-86702009000100004, 19578623.
28. Mello M, Chinaglia M. Assessment of Risk Factors for HIV Infection Among Men Who Have Sex With Men in the Metropolitan Area Of Campinas City, Brazil, Using Respondent-Driven Sampling. National STD/AIDS Program/Brazil 2008, 1-77.
29. DST/AIDS Ministério da Saúde Plano Nacional de Enfrentamento da Epidemia de AIDS e das DST entre Gays, HSH e Travestis. Ministério da Saúde 2008, In portuguese, DST/AIDS Ministério da Saúde.
30. Loschen S, Batzing-Feigenbaum J, Poggensee G, Cordes C, Hintsche B, Rausch M, Dupke S, Gohlke-Micknis S, Rodig J, Hamouda O, Kucherer C. Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections. J Clin Microbiol 2008, 46(1):341-345. 10.1128/JCM.01055-07, 2224246, 17977990.
31. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS. Estimation of HIV incidence in the United States. Jama 2008, 300(5):520-529. 10.1001/jama.300.5.520, 18677024.
32. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC. The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins hospital emergency department. J Acquir Immune Defic Syndr 2008, 48(2):211-5. 10.1097/QAI.0b013e3181743980, 2738975, 18520680.
33. Hayashida T, Gatanaga H, Tanuma J, Oka S. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2008, 24(3):495-498. 10.1089/aid.2007.0150, 18327979.
34. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted?. AIDS 2009, 23(4):485-91. 10.1097/QAD.0b013e3283269e28, 19165087.
35. Hargrove, John W. BED estimates of HIV incidence must be adjusted. AIDS 2009, 23(15):2061-2062. 10.1097/QAD.0b013e32832f3d8b, 19755864.
36. Welte A, McWalter TA, Bärnighausen T. Reply to 'Should biomarker estimates of HIV incidence be adjusted?'. AIDS 2009, 23(15):2062-2063. 10.1097/QAD.0b013e32832eff59, 19755865.
37. McDougal, J S. BED estimates of HIV incidence must be adjusted. AIDS 2009, 23(15):2064-2065. 10.1097/QAD.0b013e32832eff6e, 19755866.
38. Brookmeyer, Ron. Response to correspondence on 'Should Biomarker Estimates of HIV Incidence be Adjusted?'. AIDS 2009, 23(15):2066-2068.
39. Bastos FI, Bongertz V, Teixeira SL, Morgado MG, Hacker MA. Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret them. Mem Inst Oswaldo Cruz 2005, 100(1):91-6. 10.1590/S0074-02762005000100017, 15867971.
40. Malta M, Magnanini MMF, Mello MB, Pascom ARP, Linhares Y, Bastos FI. HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: A Systematic Review and Meta-analysis. BMC Public Health 2010, 10:317. 10.1186/1471-2458-10-317, 2898825, 20529289.
41. Scuracchio PS, Poli MC, Lemos MM, Oliveira Filho AG, Salles NA, Chamone DA, Magri M, Cavalcante NJ, Collela R. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology. Transfus Med 2007, 17(3):200-4. 10.1111/j.1365-3148.2007.00748.x, 17561863.
42. Morgado MG, Guimarães ML, Galvão-Castro B. HIV-1 polymorphism: a challenge for vaccine development - a review. Mem Inst Oswaldo Cruz 2002, 97(2):143-50. 10.1590/S0074-02762002000200001, 12016434.
43. Sá-Ferreira JA, Brindeiro PA, Chequer-Fernandez S, Tanuri A, Morgado MG. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors. Transfusion 2007, 47(1):97-102. 10.1111/j.1537-2995.2007.01069.x, 17207236.
44. de Sa-Filho DJ, Ambar RF, Duarte NB, Matias RB, Candido V, Gagliani LH, Caseiro MM. HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. AIDS Res Hum Retroviruses 2009, 25(9):925-9. 10.1089/aid.2009.0073, 19689200.